Multiple Sclerosis 
The MD Magazine Multiple Sclerosis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Low-Dose Naltrexone Appears Stable for Long-term MS Control
The authors assert that “there remains a need to identify inexpensive and non-toxic therapies that target the underlying pathophysiology of autoimmune disorders” and that “Blockade of the opioid growth factor (OGF)-OGF receptor (OGFr) pathway with low dose naltrexone (LDN) has been explored as one such therapy.”
The researchers report that “rituximab was relatively well tolerated," though complications were reported.
Scientists are working to identify factors that can accurately predict outcomes for patients with relapsing remitting multiple sclerosis (RRMS). One study found “higher baseline brain volume predicted better long-term clinical outcomes, while larger increases in Expanded Disability Status Scale score during the first 24 months predicted worse outcomes,”
Sudden hearing loss is a rare but real potential complication in multiple sclerosis.
Patients with multiple sclerosis have new ways to self-report outcome measures for sleep and sleepiness.
Patients with relapsing remitting multiple sclerosis (RRMS) who have T2 spinal cord (SC) lesions detected through magnetic resonance imaging (MRI) early in the course of the disease are likely to have a worse prognosis, according to recent research.
People who have multiple sclerosis become less likely to take risks, for both clinical and demographic reasons, a study found.
Patients with multiple sclerosis (MS) who want or need to measure their daily step-count may get the most accurate results with the waist-worn FitBit One, researchers found.
There are many ways of figuring out what stage of illness a patient with MS is experiencing and if relapse is likely. Researchers evaluated several.

Most Popular


$vacMongoViewPlus$ $vAR$